Nestlé
Search results
At Galderma, we embrace these differences and offer cutting-edge, premium brands that fit people's individual needs, across the full spectrum of dermatology through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
Galderma S.A. is a Swiss pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé , it has been held by a consortium of private institutional investors since 2019.
Galderma is the pure-play dermatology category leader, committed to advancing dermatology for every skin story. Leveraging our unique 40-year heritage of leading science-based innovation, we deliver a synergistic portfolio of flagship brands and services that span the full spectrum of dermatology.
5 days ago · Galderma , opens new tab posted net sales in the January-June period of $2.2 billion, up 10.8% on a constant currency basis, as Core EBITDA (earnings before interest, tax, depreciation and ...
5 days ago · The Investor Relations website contains information about Galderma's business for stockholders, potential investors, and financial analysts.
The mission of Galderma is to enhance people’s quality of life and contribute to a healthier future through science-based solutions for skin health.
6 days ago · Galderma Group AG, the pure-play dermatology category leader, today announced its financial results for the first half of 2024. “Galderma delivered a strong first half of the year with excellent ...
5 days ago · Commercial performance. Galderma achieved record net sales of 2.2 billion USD for the first half of 2024, representing 10.8% year-on-year net sales growth on a constant currency basis, predominantly driven by volume complemented by favorable mix.. Performance in the first half of the year was underpinned by continued execution of Galderma’s growth-focused integrated dermatology strategy and ...
Apr 24, 2024 · With a strong start to the year, Galderma confirms its full year guidance for 2024, of 7-10% net sales year-on-year growth at constant currency and a Core EBITDA margin in line with 2023 at constant currency. Galderma’s proven Integrated Dermatology Strategy
Mar 13, 2024 · After a few holdups, Swiss skincare company Galderma is finally going public in a highly anticipated market debut that could make for one of Europe’s largest listings this year.
